Literature DB >> 13655

Maternal absorption and placental transfer of sulfasalazine.

P A Hensleigh, R E Kauffman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 13655     DOI： 10.1016/0002-9378(77)90510-5

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  8 in total

Review 1.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 2.  Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy.

Authors:  W Connell; A Miller
Journal:  Drug Saf       Date:  1999-10       Impact factor: 5.606

Review 3.  Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

Review 4.  Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?

Authors:  M Ostensen; R Ramsey-Goldman
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

5.  Crohn's disease and pregnancy.

Authors:  R Khosla; C P Willoughby; D P Jewell
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

6.  Chronic idiopathic ulcerative colitis. Pregnancy and fetal outcome.

Authors:  R R Schade; D H Van Thiel; J S Gavaler
Journal:  Dig Dis Sci       Date:  1984-07       Impact factor: 3.199

7.  Ulcerative colitis and pregnancy.

Authors:  C P Willoughby; S C Truelove
Journal:  Gut       Date:  1980-06       Impact factor: 23.059

Review 8.  Optimisation of antirheumatic drug treatment in pregnancy.

Authors:  M Ostesen
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.